Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.

Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG; HIV-HBV Cohort Study of the Hepatitis B Research Network.

Hepatology. 2019 Jun 20. doi: 10.1002/hep.30825. [Epub ahead of print]

PMID:
31220357
2.

Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy.

Morse CG, McLaughlin M, Proschan M, Koh C, Kleiner DE, Heller T, Kovacs JA.

AIDS. 2015 Nov;29(17):2297-302. doi: 10.1097/QAD.0000000000000841.

3.

[Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].

Chen GF, Ping J, Gu HT, Zhao ZM, Zhou Y, Xing F, Tao YY, Mu YP, Liu P, Liu CH.

Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):145-150. doi: 10.3760/cma.j.issn.1007-3418.2017.02.013. Chinese.

PMID:
28297803
4.

Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease.

Shima T, Sakai K, Oya H, Katayama T, Mitsumoto Y, Mizuno M, Kanbara Y, Okanoue T.

J Gastroenterol. 2019 Sep 19. doi: 10.1007/s00535-019-01626-1. [Epub ahead of print]

PMID:
31538241
5.
6.

Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.

Loong TC, Wei JL, Leung JC, Wong GL, Shu SS, Chim AM, Chan AW, Choi PC, Tse YK, Chan HL, Wong VW.

J Gastroenterol Hepatol. 2017 Jul;32(7):1363-1369. doi: 10.1111/jgh.13671.

PMID:
27936280
7.

[Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].

Zhang XY, Qian J, Li P, Hu LH, Mi YQ.

Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):332-336. doi: 10.3760/cma.j.issn.1007-3418.2018.05.004. Chinese.

PMID:
29996199
8.
9.

Letter to the Editor: Non-invasive markers of advanced liver fibrosis in HBV/HIV coinfected patients.

Huang R, Wang J, Yan X, Zhang Z, Wu C.

Hepatology. 2019 Aug 20. doi: 10.1002/hep.30903. [Epub ahead of print]

PMID:
31430388
10.

Impact of Implementing a "FIB-4 First" Strategy on a Pathway for Patients With NAFLD Referred From Primary Care.

Davyduke T, Tandon P, Al-Karaghouli M, Abraldes JG, Ma MM.

Hepatol Commun. 2019 Jul 29;3(10):1322-1333. doi: 10.1002/hep4.1411. eCollection 2019 Oct.

11.

Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.

Fouad R, Elbaz T, Abdel Alem S, Elsharkawy A, Negm M, Khairy M, Hassany M, Cordie A, El Akel W, Esmat G.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):882-887. doi: 10.1097/MEG.0000000000001151.

PMID:
29727382
12.

Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.

Ragazzo TG, Paranagua-Vezozzo D, Lima FR, de Campos Mazo DF, Pessoa MG, Oliveira CP, Alves VAF, Carrilho FJ.

Clinics (Sao Paulo). 2017 Oct;72(9):516-525. doi: 10.6061/clinics/2017(09)01.

13.

Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.

Chalouni M, Sogni P, Miailhes P, Lacombe K, Poizot-Martin I, Chas J, Vittecoq D, Neau D, Aumaitre H, Alric L, Piroth L, Bouchaud O, Katlama C, Morlat P, Lascoux-Combe C, Gervais A, Naqvi A, Rosenthal E, Garipuy D, Barange K, Esterle L, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group.

Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1387-1396. doi: 10.1097/MEG.0000000000001408.

PMID:
31033848
14.

Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.

Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, Lei XZ, Liu C, Tang H.

Dig Dis Sci. 2011 Sep;56(9):2742-9. doi: 10.1007/s10620-011-1659-1. Epub 2011 Mar 12.

PMID:
21399926
15.

The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease.

Tapper EB, Challies T, Nasser I, Afdhal NH, Lai M.

Am J Gastroenterol. 2016 May;111(5):677-84. doi: 10.1038/ajg.2016.49. Epub 2016 Mar 15.

16.

Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.

Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH.

J Formos Med Assoc. 2015 Oct;114(10):923-8. doi: 10.1016/j.jfma.2015.07.004. Epub 2015 Aug 13.

17.

Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients.

Tseng CH, Chang CY, Mo LR, Lin JT, Tai CM, Perng DS, Lin CW, Hsu YC.

Ann Hepatol. 2018 Aug 24;17(5):789-794. doi: 10.5604/01.3001.0012.3137.

18.

Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.

Xiao G, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Yan L, Qin R.

Dig Liver Dis. 2016 Oct;48(10):1220-6. doi: 10.1016/j.dld.2016.06.001. Epub 2016 Jun 15.

PMID:
27599803
20.

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC; Chronic Hepatitis Cohort Study (CHeCS) Investigators.

Clin Infect Dis. 2013 Jul;57(2):240-6. doi: 10.1093/cid/cit245. Epub 2013 Apr 16.

Supplemental Content

Support Center